This trial is testing a new drug for lupus patients who are not responding to current treatments.
1 Primary · 10 Secondary · Reporting Duration: Baseline through Week 60
Experimental Treatment
Non-Treatment Group
360 Total Participants · 2 Treatment Groups
Primary Treatment: Medi-546 · Has Placebo Group · Phase 3
Age 18 - 70 · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:California | 50.0% |
Michigan | 50.0% |
18 - 65 | 100.0% |
Research Site | 100.0% |
Did not meet criteria | 50.0% |
Met criteria | 50.0% |